Your comprehensive evidence-based neurology knowledge base.
347 topics across 9 neurology specialties
Functional Outcomes & Scales
Standardized outcome measurement is fundamental to modern neurorehabilitation, serving as the common language for clinical trials, quality improvement, prognostication, and demonstration of treatment efficacy. The choice of outcome measure should be guided by the research question, the ICF domain of interest, the patient population, and practical considerations including sensitivity to change, floor/ceiling effects, and ease of administration. This topic provides a comprehensive overview of the most important outcome measures used in stroke rehabilitation and neurorehabilitation more broadly, along with frameworks for selecting the right tool for the right purpose.
Bottom Line
Modified Rankin Scale (mRS): The most commonly used primary endpoint in acute stroke trials; measures global disability on a 0–6 scale; a structured interview improves interrater reliability.
NIHSS: The standard for acute stroke severity assessment (0–42); biased toward left hemisphere and anterior circulation deficits; limited for posterior circulation stroke.
Functional Independence Measure (FIM): The most widely used measure in inpatient rehabilitation; 18 items scored 1–7; captures both motor and cognitive function.
Gait speed (10-meter walk test): A powerful, simple measure; <0.4 m/s = household ambulator, 0.4–0.8 m/s = limited community, >0.8 m/s = full community ambulator.
MoCA: The preferred cognitive screening tool for post-stroke cognitive impairment; more sensitive than MMSE for vascular cognitive impairment.
Minimal clinically important difference (MCID): The smallest change that matters to patients — critical for interpreting whether a statistically significant change is clinically meaningful.
ICF framework: Guides outcome selection by distinguishing body functions/structures, activity, and participation levels.
The ICF Framework
The World Health Organization’s International Classification of Functioning, Disability and Health (ICF) provides the conceptual framework for understanding and selecting outcome measures in rehabilitation.
ICF Level
Definition
Examples of Measures
Clinical Relevance
Body Functions & Structures
Impairments in physiological or psychological functions or anatomical structures
NIHSS, Fugl-Meyer Assessment, Modified Ashworth Scale, MoCA, visual field testing
Most specific to the neurological deficit; useful for understanding mechanisms and targeting treatment
Activity
Ability to execute tasks or actions; limitations = “activity limitations”
Barthel Index, FIM, 10-meter walk test, Action Research Arm Test, Box and Block Test
Closest to what patients and caregivers experience daily; most commonly used in rehabilitation research
Participation
Involvement in life situations; restrictions = “participation restrictions”
Stroke Impact Scale, EQ-5D, return to work, community integration, social roles
Hardest to measure; most meaningful to patients; influenced by environmental and personal factors beyond neurological impairment
Contextual Factors
Environmental factors (physical, social, attitudinal) and personal factors (age, coping, motivation)
Caregiver Burden Scale, social support measures, environmental assessment
Powerful modifiers of outcome; often not formally measured but critical for understanding individual trajectories
Stroke-Specific Outcome Measures
NIHSS (National Institutes of Health Stroke Scale)
Item
Domain
Score Range
1a
Level of consciousness
0–3
1b
LOC questions (month, age)
0–2
1c
LOC commands (open/close eyes, grip/release)
0–2
2
Best gaze (horizontal eye movements)
0–2
3
Visual fields
0–3
4
Facial palsy
0–3
5
Motor arm (L & R separately)
0–4 each
6
Motor leg (L & R separately)
0–4 each
7
Limb ataxia
0–2
8
Sensory
0–2
9
Best language (aphasia)
0–3
10
Dysarthria
0–2
11
Extinction and inattention (neglect)
0–2
NIHSS Key Points
Total score range: 0–42 (higher = more severe)
Severity categories: 0–4 minor, 5–15 moderate, 16–20 moderate-severe, 21–42 severe
Left hemisphere bias: Language items (aphasia 0–3, dysarthria 0–2) add more points for left hemisphere strokes; a right hemisphere stroke with severe neglect and anosognosia may score deceptively low
Anterior circulation bias: Poor capture of posterior circulation deficits (vertigo, diplopia, dysphagia, coordination); a devastating basilar artery occlusion may score only 2–4 on NIHSS
No cognitive assessment beyond language and neglect
Able to carry out all usual activities; minor symptoms (e.g., subtle aphasia, mild weakness)
2
Slight disability
Unable to carry out all previous activities but able to look after own affairs without assistance
3
Moderate disability
Requires some help but able to walk without assistance
4
Moderately severe disability
Unable to walk without assistance; unable to attend to own bodily needs without assistance
5
Severe disability
Bedridden, incontinent, requires constant nursing care and attention
6
Dead
—
mRS Key Points
Most commonly used primary endpoint in acute stroke trials (e.g., thrombolysis trials, thrombectomy trials)
Key trial cutoffs: mRS 0–1 = excellent outcome; mRS 0–2 = good outcome (most commonly used dichotomous endpoint in trials); mRS 3 = moderate disability (independent with aids)
Shift analysis: Modern trials increasingly use ordinal shift analysis (comparing entire mRS distribution) rather than dichotomized outcomes, as this provides greater statistical power
Structured interview (mRS-SI): Wilson et al. developed a structured interview that significantly improves interrater reliability compared to unstructured assessment; now recommended for all clinical trials
Limitations: Broad categories lack sensitivity to change within categories; subjective weighting of disability domains; less useful in rehabilitation (too insensitive to detect incremental gains)
Strengths: Simple, widely used, well-validated, good reliability
Limitations:Ceiling effect in mild strokes (patients may score 100 but still have significant disability in instrumental ADLs); ordinal, not interval data; does not capture cognitive function
Functional Independence Measure (FIM)
FIM Overview
Structure: 18 items, each scored 1 (total assistance) to 7 (complete independence); total score 18–126
Most used outcome measure in inpatient rehabilitation in the US; required for IRF-PAI (Inpatient Rehabilitation Facility – Patient Assessment Instrument)
FIM gain: Discharge FIM − admission FIM; FIM efficiency = FIM gain / length of stay; used as a quality benchmark in rehabilitation facilities
Limitations: Copyright-protected (requires licensing); ceiling and floor effects; cognitive subscale limited; does not capture community participation
Upper Limb Outcome Measures
Measure
Items/Score
Time
What It Measures
Strengths/Limitations
Fugl-Meyer Assessment – Upper Extremity (FMA-UE)
33 items; 0–66
30–40 min
Impairment-level motor function through Brunnstrom stages; voluntary movement, coordination, reflex activity, speed
Gold standard for UE motor impairment; detailed; research standard; time-consuming; floor effect in severe patients
Good responsiveness; widely used in clinical trials; hierarchical structure allows abbreviated testing
Wolf Motor Function Test (WMFT)
17 items (time + quality)
30 min
Timed performance of functional tasks from simple (forearm to table) to complex (lift basket)
Primary outcome in EXCITE trial (CIMT); captures both ability and quality/speed; time-consuming
Box and Block Test
Blocks moved in 60 seconds
2–5 min
Gross manual dexterity; unilateral gross grasp and release
Simple, quick, reliable; limited to single aspect of hand function
9-Hole Peg Test
Time to complete (seconds)
2–5 min
Fine manual dexterity; precision grasp and placement
Quick, widely used (also in MS research); floor effect — many stroke patients unable to attempt
Gait and Mobility Measures
Measure
Administration
What It Measures
Key Thresholds/Notes
10-Meter Walk Test (10MWT)
Walk 10 meters; time the middle 6 meters (to exclude acceleration/deceleration); calculate speed (m/s)
Gait speed — comfortable and fast speeds
<0.4 m/s: household ambulator 0.4–0.8 m/s: limited community ambulator >0.8 m/s: full community ambulator MCID ≈ 0.16 m/s; simple, powerful predictor of function and health status
6-Minute Walk Test (6MWT)
Walk as far as possible in 6 minutes on a measured course
Walking endurance; cardiovascular fitness
MCID ≈ 50 meters; correlates with community ambulation; distance reflects real-world walking capacity
Timed Up and Go (TUG)
Rise from chair, walk 3 meters, turn, return, sit down; time in seconds
Functional mobility, balance, fall risk
>14 seconds associated with increased fall risk; quick bedside screen; limited sensitivity in higher-functioning patients
Berg Balance Scale (BBS)
14 items scored 0–4; total 0–56
Static and dynamic balance during functional tasks
<45 associated with increased fall risk; ceiling effect in mild patients; widely used in rehabilitation
Functional Ambulation Categories (FAC)
6-point scale (0–5)
Level of human assistance needed for ambulation
0 = non-ambulatory; 5 = independent everywhere including stairs; simple; useful for broad classification
Gait Speed as a “Vital Sign”
Gait speed has been proposed as the “sixth vital sign” due to its powerful predictive value for hospitalization, falls, functional decline, and mortality
The 10-meter walk test is one of the simplest and most informative measures available; it should be routinely assessed in all ambulatory stroke survivors
The community ambulation threshold categories (<0.4, 0.4–0.8, >0.8 m/s) provide immediately actionable clinical information about a patient’s functional mobility level
Cognitive Outcome Measures
Measure
Score Range
Time
Best Use
MoCA (Montreal Cognitive Assessment)
0–30 (≤25 abnormal)
10 min
Preferred screen for post-stroke and vascular cognitive impairment; assesses visuospatial, executive, attention, language, memory, orientation
MMSE (Mini-Mental State Examination)
0–30 (≤24 abnormal)
7–10 min
General cognitive screen; less sensitive than MoCA for vascular/executive deficits; better for Alzheimer screening
Most validated biomarker-based prediction tool for motor recovery (see Motor Recovery topic)
Minimal Clinically Important Difference (MCID)
The MCID represents the smallest change in an outcome measure that patients perceive as beneficial and that would justify a change in clinical management. It is essential for determining whether a statistically significant result in a trial is clinically meaningful.
Outcome Measure
MCID
Context/Notes
Modified Rankin Scale (mRS)
1 point
Represents a meaningful change in global disability level; shift analysis considers the entire distribution
NIHSS
2–4 points
Varies by baseline severity; larger change needed to be meaningful at higher baseline scores
10-Meter Walk Test
0.16 m/s
Crossing a community ambulation threshold (e.g., from <0.4 to >0.4 m/s) is especially meaningful
6-Minute Walk Test
50 meters
Approximately 20% improvement from typical post-stroke baseline
Fugl-Meyer Assessment – UE
5–10 points
5 points for early phase; 10 points for chronic phase (when spontaneous recovery is minimal, larger changes are needed to be perceived as meaningful)
Action Research Arm Test (ARAT)
5.7–12 points
Varies by study and baseline severity
Barthel Index
~10 points
Corresponds to becoming independent in 1–2 ADL items
Functional Independence Measure (FIM)
22 points (motor)
Total FIM; domain-specific MCIDs also established
Berg Balance Scale
3–7 points
Crossing below 45 (fall risk threshold) is especially clinically relevant
Timed Up and Go
2.9 seconds
Especially meaningful when crossing the 14-second fall risk threshold
Quality Metrics in Stroke Care
Beyond individual patient outcomes, system-level quality metrics are essential for benchmarking stroke care quality and driving improvement.
Quality Metric
Target
Rationale
Door-to-needle time (IV tPA)
≤60 minutes
Every 15-minute delay in tPA reduces favorable outcomes; AHA/ASA target ≤60 minutes from ED arrival
Door-to-puncture time (thrombectomy)
≤90 minutes
Faster reperfusion improves outcomes; systems of care optimization critical
Stroke unit care
All stroke patients
Organized stroke unit care reduces mortality and disability (Stroke Unit Trialists meta-analysis); NNT ~20 to prevent one death or dependency
Dysphagia screening
Before any oral intake
Reduces aspiration pneumonia; bedside swallow screen or formal assessment
DVT prophylaxis
All immobilized patients
Pharmacologic (LMWH/heparin) or mechanical (IPC) prophylaxis; CLOTS-3 supports IPC when pharmacologic contraindicated
Early mobilization
24–48 hours
AVERT trial: early mobilization beneficial but not within first 24 hours and not at very high intensity
Match to ICF level: Is the question about impairment (use FMA, NIHSS, MAS), activity (use FIM, Barthel, gait speed), or participation (use SIS, EQ-5D)?
Match to patient population: Avoid measures with floor effects in severe patients (ARAT in patients with no hand movement) or ceiling effects in mild patients (Barthel Index in mRS 0–1 patients)
Consider responsiveness: The measure must be sensitive enough to detect the expected change over the study period; FMA-UE is more responsive than ARAT for detecting early motor recovery
Practical considerations: Training requirements, time to administer, copyright/licensing costs, availability of normative data
Use multiple levels: A comprehensive assessment battery should include measures at impairment, activity, and participation levels to capture the full impact of the neurological condition and the rehabilitation intervention
Include patient-reported outcomes: What patients perceive and value may differ from what clinicians measure; PROs capture the patient perspective and are increasingly required in clinical trial design
References
Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870.
van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607.
Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33(9):2243–2246.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–65.
Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6–18.
Fugl-Meyer AR, Jaasko L, Leyman I, et al. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13–31.
Perry J, Garrett M, Gronley JK, Mulroy SJ. Classification of walking handicap in the stroke population. Stroke. 1995;26(6):982–989.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
Duncan PW, Wallace D, Lai SM, et al. The Stroke Impact Scale version 2.0: evaluation of reliability, validity, and sensitivity to change. Stroke. 1999;30(10):2131–2140.
Tilson JK, Sullivan KJ, Cen SY, et al. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2010;90(2):196–208.
Page SJ, Fulk GD, Boyne P. Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Phys Ther. 2012;92(6):791–798.
World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: WHO; 2001.
Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;(9):CD000197.
Hsueh IP, Lin JH, Jeng JS, Hsieh CL. Comparison of the psychometric characteristics of the functional independence measure, 5 item Barthel index, and 10 item Barthel index in patients with stroke. J Neurol Neurosurg Psychiatry. 2002;73(2):188–190.
